To validate whether down regulation of GNG4 transcript levels is indeed a direct effect of promoter methylation, methylation inhibitor (azacytidine) treatment was carried out in GBM cell lines and this indeed resulted in the re-expression of GNG4 transcript to varying levels (Figure 1E). Here, GNG4 is linked to glioblastoma.